Approximately 12% of the world's population have a have a common C677T polymorphism in the gene encoding the folate metabolising enzyme, methylenetetrahydrofolate reductase (MTHFR). Homozygosity for the polymorphism (TT genotype) appears to result in an increased requirement for the B-vitamins folic acid and riboflavin and more importantly results in an increased risk of developing high blood pressure (BP). Previous work from our Centre has demonstrated significantly higher BP in those with the TT genotype. This work has been conducted in cohorts with premature cardiovascular disease (CVD) and hypertension without overt CVD, but the effect in younger, healthier individuals is unexplored. To date our studies have also focused on BP as the primary outcome, but newer markers of vascular health including central pressure and hemodynamics have emerged as superior prognostic indicators of CVD. The effect of the TT genotype on these measures is thus an important area for investigation and may help us understand the mechanism linking the genotype with BP, which is currently unknown. As adults with the TT genotype appear to have increased requirements for riboflavin and folic acid, and BP in TT adults appears to be riboflavin dependent, the influence of these vitamins on central measures is an area for consideration. Study Design This is an observational study investigating the blood pressure profiles of healthy adults aged 18-65 years, stratified by MTHFR genotype. Apparently healthy adults will be recruited from workplaces and the general community across Northern Ireland and screened for the polymorphism via buccal swab. Those with the TT genotype and a similar number of non-TT (i.e. CC/CT) genotype individuals will be contacted and asked to come to attend a one-off appointment. Brachial BP will be assessed by an electronic BP monitor, central BP and central haemodynamics (augmentation index, augmentation pressure and pulse wave velocity) will be assessed by SphygmoCor XCEL. In addition, anthropometric measurements, health and lifestyle information and a blood sample will be obtained. Data will be statistically analysed using SPSS software to if determine differences between gentoype groups exist.
Study Type
OBSERVATIONAL
Enrollment
498
Human Intervention Studies Unit, Ulster University
Coleraine, Co.Londonderry, United Kingdom
Blood pressure
Office blood pressure
Time frame: One day, one measurement
Brachial blood pressure
Measured using SphygmoCor device
Time frame: One day, one measurement
Central blood pressure
Measured using SphygmoCor device
Time frame: One day, one measurement
Pulse wave analysis
Measured using SphygmoCor device
Time frame: One day, one measurement
Pulse wave velocity
Measured using SphygmoCor device
Time frame: One day, one measurement
Riboflavin status
Measured by by EGRac
Time frame: One day, one measurement
Folate status
Measured by microbiological assay
Time frame: One day, one measurement
PLP status
Measured by HPLC
Time frame: One day, one measurement
Homocysteine status
Measured by GCMS
Time frame: One day, one measurement
One-carbon metabolite status
Measured by GCMS-MS
Time frame: One day, one measurement
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.